Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-17

Clinical Trial Update: Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

View source ↗

Summary

This update reports the completion of an observational study of patients with moderate to severe chronic plaque psoriasis, sponsored by AbbVie.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AbbVie | Conditions: Chronic Plaque Psoriasis | Status: COMPLETED